Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation

Clermont AC, Murugesan N, Edwards HJ, Lee DK, Bayliss NP, Duckworth EJ, Pethen SJ, Hampton SL, Gailani D, Feener EP

Treatment of Hereditary Angioedema (HAE) with Normal C1-INH (HAE-nC1-INH) –A Real-World ACARE Survey

Maurer M, Magerl M, Riedl MA, Danese S, Ulloa J, Desai V, Audhya PK

Riedl MA, Magerl M, Maurer M, Danese S, Ulloa J, Desai V, Audhya PK

Magerl M , Riedl MA, Maurer M, Danese S, Ulloa J, Desai V, Audhya PK

Savic S, El-Shanawany T, Gurugama P, Jain R, Danese S, Ulloa J, Desai V, Audhya PK, Yong P

El-Shanawany T, Yong P, El-Shanawany T, Gurugama P, Jain R, Danese S, Ulloa J, Desai V, Audhya PK, Savic S

Tachdjian R, Savic S, Fridman M, Frade JP, Fasehun M, Audhya PK

Geng B, van Kooten S, Heckmann M, Danese S, Goga L, Radojicic C

Marcus Maurer M, Markus Magerl M, Marc A, Riedl MA, Sherry Danese S, Julie Ulloa J, Vibha Desai V, Paul K, Audhya PK

Tachdjian R, Chang R, DerSarkissian M, Cribbs KA, Lahue BJ, Czado S, Desai V